Covers all Aspects of Neurology Startups Drug Development Intelligence
Updated knowledge everytime
NS 2020 is a key update over previous report NS 2017, as it covers 189 more Neurology Startups Drug Developers than the previous report. It also abandoned 69 companies, which were earlier covered in NS 2017, which were either acquired/merged or closed during the period.
complete intelligence at fingertips
Worldwide Extensive Coverage
Formed after 2010; with Market Valuation less then $500Mn USD
Largest Early Stage Developmental Pipeline Details
Covers exclusive Neurology focused deals, partnering with BIG Pharma, CROs etc.
intelligence supercharged
Provides Complete Landscape on Latest Neurology Drug Development covering Emerging Technologies, Partnering and Funding Status in the Domain.
Also, Startups having proper funding, technologies and pipeline are only included. No Acquired, Merged or Dormant Stage Neurology Drug Developer is included.
Report is highly precise and designed keeping in mind to keep information intact, informative and self explanatory. Also, every piece of intelligence is cross validated.
Only facts, no guess work.
300+ Pages present complete picture of individual company’s pipeline, deals, partnering, funding etc. and outline individual startup’s core strength and stand with respect to other startups.
Report documents all Neurology focused news/deals of every startups since incorporation. Making it perfect tool for Decision Making and a big time saver too.
Compares Oranges with Oranges.
Only Active Neurology Drug Developing Startups, with no room to Diagnostic and Device companies; making data clear and impactful.
Most of the intelligence provider covers limited number of known companies, that too many of which have no links to the core title of the report. Also many renowned database too contains acquired/closed companies, thus driving final intelligence too tedious and time consuming exercise.
All our reports provides comprehensive intelligence, with largest active industry coverage and avoids investing money on other similar resources. Thus, saves lots of resources in terms of time and money, in identifying new partnering opportunities.
Each year, we publish very small number of comprehensive reports and are experts in identifying and tracking startups. We maintain our own database and track’s every individual company.
From last 10 years, our team exclusively providing marketing intelligence in field of Oncology and Neurology Drug Development.
Neurology Startups 2020, is highly innovative and precise report designed to identify and capture the outlook of early stage neurology drug developers companies present in 26 countries worldwide.
The report provides complete landscape on Top 370 Neurology Drug Developing startups established during 2010-2016, and without any doubt is one of the world’s largest focused data coverage on Active Neurology Drug Developers.
Neurology Startups 2020, is unique in many aspects as it for the first time provides neurology startups ranking, based on individual company’s overall score on five major parameters- venture funding, key management, technology, deals & partnerships and cancer focused pipeline. The report, also provides quick infographics and final intelligence to keep information on fingertips.
Key Highlights –
Neurology Startups 2020 is based on picking Top 370 Active Neurology Drug Developers, selected from over 500+ companies established during the duration, with validated funding and neurology drug pipeline. Report covers only active neurology targeting (treatment) companies excluding Merged, Dormant or Simply Idea based companies. Also, Report does not includes neurology diagnostic companies.
The Report will help various organizations working on cancer research, to supercharge with lots of new decision making information and jump-start their current partnering/marketing efforts.
Executive Summary
List of Figures
List of Tables
List of Top 370 Neurology Startups
Infographics – Quantitative Estimation of Neurology Startups present in U.S.A vs. Europe vs. Asia vs.Canada vs. Rest of the World (established between Jan 2010 to Sep 2019).
Infographics – Distribution of Top 370 Neurology Startups, on the basis of Year of Establishment. (To explore the emergence of Neurology Drug Discovery And Development.)
Infographics – Country-wise Distribution of Neurology Startups having Active Neurology Drug Development Program in Europe and Asia Region. (To identify best and emerging countries, for promoting neurology startups)
Infographics – State-wise Distribution of Neurology Startups having Active Neurology Drug Development Program in U.S.A. (To explore the Top neurology startups supporting States in United States).
Intelligence – Top 20 Innovative Game Changer Neurology Startups.
Capable of changing tomorrow’s Neurology Drug Discovery & Development.
Intelligence – Stem Cell Therapy Developing Neurology Startups. (15 Startups)
Intelligence – Gene Therapy Developing Neurology Startups. (21 Startups)
Drugs in Development by Neuro Startups – Alzheimer’s Disease. (76 Startups)
Drugs in Development by Neuro Startups – Parkinson Disease. (70 Startups)
Drugs in Development by Neuro Startups – Pain Treatment. (41 Startups)
Drugs in Development by Neuro Startups – Multiple Sclerosis. (32 Startups)
Drugs in Development by Neuro Startups – Epilepsy. (26 Startups)
Drugs in Development by Neuro Startups – Ischemic Stroke & Traumatic Brain Injury. (26 Startups)
Drugs in Development by Neuro Startups – Schizophrenia. (14 Startups)
Neurology Startups – Major Deals & Partnering Activities in 2019. (up till Sep. 2019)
Neurology Startups – Major Deals & Partnering Activities in 2018. (37 Deals)
Neurology Startups – Major Deals & Partnering Activities in 2017. (30 Deals)
Neurology Startups – Venture Funding – 2019. (up till Sep. 2019)
Including Seed Funding, Equity Funding with Series Round A/B/C/D details; IPO; Debt Funding and Grants.
Neurology Startups – Venture Funding – 2018 (75 Records)
Including Seed Funding, Equity Funding with Series Round A/B/C/D details; IPO; Debt Funding and Grants.
Neurology Startups – Venture Funding – 2017 (47 Records)
Including Seed Funding, Equity Funding with Series Round A/B/C/D details; IPO; Debt Funding and Grants.
Key Venture Capital Investors in Neurology Startups and their Investment Portfolio.
Atlas Ventures, Roche Venture Fund, Lilly Ventures, Third Rock Ventures and Avlon Ventures.
Intelligence – Key Neurology Startups supported by The Michael J. Fox Foundation for Parkinson’s Research.
Neurology Drug Developer Profiles of Active Neurology Startup Companies (370 Companies)
Individual Company Pages includes: Company Profile, Key technology platform, Venture Funding Rounds, Neurology centered Deals & Partnership, Collaborations and Business Insights.
Neurology Drug Pipeline –Drugs name, its targets, with details of its development for various indications for cancer cure, FDA/EMEA Orphan drug status.
Management Profile –Address, Contact number, e-mail, Key Management / Decision Maker (CXOs) name and designation, with individual Linked ID and contact emails.
Appendix A: Country Wise List of 370 Neurology Startup Companies.
Appendix B: Complete 448 Molecules List, along with their Developer’s Name.
Table A.1 Intelligence – Top 20 Highly Innovative Startups capable of changing future of Neurology Drug Discovery & Development.
Table A.2 Stem Cell targeting Neurology Startups & their Technologies (15 Companies).
Table A.3 Gene Therapy focused Neurology Startups & their Technologies (21 Companies).
Table A.4 Research Pipeline – Alzheimer’s Disease – Developer Name, Molecule, Target & Developmental Stage.
Table A.5 Research Pipeline – Parkinson Disease – Developer Name, Molecule, Target & Developmental Stage.
Table A.6 Research Pipeline – Pain Disease – Developer Name, Molecule, Target & Developmental Stage.
Table A.7 Research Pipeline – Amyotrophic Lateral Sclerosis – Developer Name, Molecule, Target & Developmental Stage.
Table A.8 Research Pipeline – Multiple Sclerosis – Developer Name, Molecule, Target & Developmental Stage.
Table A.9 Research Pipeline – Epilepsy – Developer Name, Molecule, Target & Developmental Stage.
Table A.10 Research Pipeline – Ischemic Stroke & Traumatic Brain Injury – Developer Name, Molecule, Target & Developmental Stage.
Table A.11 Research Pipeline – Schizophrenia – Developer Name, Molecule, Target & Developmental Stage.
Table B.1Â Intelligence – Neurology Startups Major Deals & Partnering Activities – 2019 (uptill Sep. 2019).
Table B.2Â Intelligence – Neurology Startups Major Deals & Partnering Activities – 2018.
Table B.3Â Intelligence – Neurology Startups Major Deals & Partnering Activities – 2017.
Table B.4Â Intelligence – Neurology Startups Funding – 2019 (uptill Sep. 2019).
Table B.5Â Intelligence – Neurology Startups Funding – 2018.
Table B.6Â Intelligence – Neurology Startups Funding – 2017.
Table B.7Â Top 5 Venture Investors in Neurology Startups and Their Investment Portfolio – Atlas Ventures.
Table B.8 Top 5 Venture Investors in Neurology Startups and Their Investment Portfolio – Roche Venture Fund.
Table B.9 Top 5 Venture Investors in Neurology Startups and Their Investment Portfolio – Lilly Ventures.
Table B.10 Top 5 Venture Investors in Neurology Startups and Their Investment Portfolio – Third Rock Ventures.
Table A.11 Top 5 Venture Investors in Neurology Startups and Their Investment Portfolio – Avlon Ventures.
Table A.12 Key Neurology Startups supported by The Michael J. Fox Foundation for Parkinson’s Research.
Our Report Buyers
During checkout, under payment method opt for wire transfer method. On completion the order you will receive an auto generated Invoice in your email, with our bank account and other wire transfer details; or directly reach out at sales@omicsx.com to raise required Invoice.
Single step one click secured Express Checkout through PayPal gateway. Report will be delivered in few minutes directly in your inbox after payment confirmation.
